Harvard Bioscience HBIO Cash Flow Statement (2010-2026)

NASDAQ HBIO
$8.34 +0.25 (+3.09%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Harvard Bioscience Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Harvard Bioscience reported cash from operations of $0.33M and free cash flow of -$0.36M for the quarter ended Jun 2026, down 88.2% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.17M0.96M-6.88M2.44M-3.41M-1.67M0.62M-0.98M-1.24M-1.82M-4.69M-2.93M-4.80M0.02M-50.34M-2.28M-1.23M-2.85M-3.42M-2.91M
Depreciation and DepletionDep. & Depletion
0.42M0.47M0.38M0.38M0.36M0.33M0.33M0.33M0.42M0.42M0.40M0.43M0.44M0.46M0.45M0.41M0.43M0.46M0.44M0.47M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
1.46M1.45M1.47M1.45M1.57M1.63M1.39M1.39M1.36M1.39M1.38M1.37M1.38M1.30M1.20M1.21M0.90M0.89M0.91M0.91M
Amortization of Deferred ChargesAmort. Deferred Charges
0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.09M0.10M0.13M0.21M0.36M0.62M0.45M0.50M
Depreciation & Amortization (CF)Dep. & Amort.
0.42M0.47M0.38M0.38M0.36M0.33M0.33M0.33M0.42M0.42M0.40M0.43M0.44M0.46M0.45M0.41M0.43M0.46M0.44M0.47M
Share-based CompensationStock Comp.
1.00M1.03M1.02M1.24M1.14M1.01M1.15M1.10M1.36M1.38M1.05M1.28M1.05M0.96M0.60M0.47M0.32M0.46M0.26M0.38M
Deferred Taxes
0.20M-0.17M0.12M-1.16M1.20M0.25M0.06M-0.14M-0.01M-0.24M-0.18M-0.23M0.77M-0.72M0.52M0.05M-0.02M0.13M0.09M0.01M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
0.40M
Gains from Investment SecuritiesGains Investment
-1.58M1.21M-0.26M-1.31M-0.28M
Asset Writedowns and ImpairmentWritedown
48.00M
Cash from Restructuring
Other non-cash itemsOther Non-Cash
1.24M-1.24M1.36M
Change in Working Capital
Change in ReceivablesChange Receivables
1.05M3.57M-1.51M-2.08M-2.47M1.28M0.92M-0.86M-1.82M0.94M-0.70M-2.75M0.16M2.33M-1.44M-1.79M0.21M3.96M-1.41M-0.06M
Change in InventoryChange Inventory
1.52M1.81M1.31M1.36M-2.34M-0.58M0.29M-0.69M0.23M-1.35M0.62M1.13M0.67M-2.35M-0.67M-0.98M-0.64M-0.66M1.54M0.18M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
0.27M0.55M2.73M-3.16M-1.94M0.98M-0.15M-0.12M-0.03M-0.23M2.04M-2.31M-0.01M-1.50M1.47M0.30M-0.27M0.80M1.18M0.38M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
0.57M-1.65M0.47M-0.22M0.56M-1.29M0.31M0.96M-1.32M-1.60M0.30M0.52M-1.69M-0.77M-0.03M-0.02M-0.37M-1.10M0.39M-0.78M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.38M-0.86M-0.39M-0.80M-0.20M-0.01M0.38M-0.55M0.81M0.50M-0.12M-0.38M-0.32M0.12M-0.10M-0.31M-1.16M1.05M0.36M-0.11M
Other Working Capital ChangesOther WC Changes
-0.95M0.79M-0.85M-0.59M-0.76M1.28M0.07M-1.51M2.12M2.10M-0.42M-0.89M1.37M0.89M-0.07M-0.28M-0.79M2.15M-0.03M0.67M
Cash from OperationsCash from Ops.
-0.66M0.12M-1.99M-0.19M0.65M2.68M1.81M3.55M4.36M4.30M1.40M-0.85M-0.84M1.73M2.99M2.76M1.08M-0.10M-0.66M0.33M
Investing Activities
Capital ExpendituresCapex
0.48M0.36M0.47M0.44M0.44M0.24M0.22M0.52M0.22M0.83M0.65M0.82M0.88M0.30M0.51M0.09M0.21M0.45M0.43M0.69M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.48M-0.36M-0.47M-0.44M-0.44M-0.24M-0.22M-0.52M-0.22M-0.83M-0.65M-0.82M-0.88M-0.30M-0.51M-0.09M-0.21M-0.45M-0.43M-0.69M
Change in IntangiblesChange Intangibless
0.11M0.18M0.23M0.08M0.15M0.23M0.17M0.17M0.14M0.14M0.15M0.19M0.23M
Acquisitions
Divestments
0.51M
Net of Acquisitions & DivestmentsNet Acquisitions
0.51M
Sale and Maturity of InvestmentsInvestments Sold
0.50M1.42M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.48M-0.36M-0.47M-0.44M-0.44M-0.24M0.29M-0.63M-0.40M-1.06M-0.23M0.46M-1.11M-0.47M-0.68M-0.23M-0.35M-0.60M-0.62M-0.92M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
2.50M1.75M
Long-Term Debt RepaymentsLT Debt Repayment
0.50M0.50M0.94M0.75M0.75M0.75M1.84M0.75M0.75M0.75M3.02M1.00M1.00M1.00M1.00M1.00M1.00M21.70M
Non-Current Debt
2.00M1.25M-0.94M-0.75M-0.75M-0.75M-1.84M-0.75M-0.75M-0.75M-3.02M-1.00M-1.00M-1.00M-1.00M-1.00M-1.00M-21.70M
Short-Term Debt issuancesST Debt Issuance
2.50M1.75M1.50M3.80M2.50M1.50M1.00M1.00M1.00M2.50M3.05M3.25M
Short-Term Debt repaymentsST Debt Repayment
-1.80M3.60M1.05M1.75M2.50M2.95M3.00M2.50M0.50M2.05M12.65M
Current Debt
2.50M3.55M1.50M0.20M1.45M-1.75M-1.00M-1.95M-2.00M-1.50M2.00M1.00M3.25M-12.65M
Net Debt Issuances and RepaymentsNet Debt Issuance
4.50M4.80M0.56M-0.55M0.70M-2.50M-2.84M-2.70M-2.75M-2.25M-1.02M2.25M-1.00M-1.00M-1.00M-1.00M-34.35M
Change in Capital Stock
Common Stock IssuedStock Issued
0.15M0.41M0.03M0.25M0.06M0.23M0.10M0.62M0.21M0.02M0.19M0.02M0.16M0.05M0.00M0.15M
Net Shares Issued and RepurchasedNet Shares Issued
0.15M0.41M0.03M0.25M0.06M0.23M0.10M0.62M0.21M0.02M0.19M0.02M0.16M0.05M0.00M0.15M
Net Equity Issued and RepurchasedNet Equity Issued
0.15M0.41M0.03M0.25M0.06M0.23M0.10M0.62M0.21M0.02M0.19M0.02M0.16M0.05M0.00M0.15M
Other financing activitiesOther financing
-1.66M-1.72M-0.50M-0.28M-0.39M-0.46M-0.16M-0.30M-2.07M-0.05M-0.01M-0.22M-1.04M-0.28M-0.02M-3.26M-0.19M-0.04M
Cash from Financing ActivitiesCash from Financing
0.49M2.59M0.09M-0.58M0.38M-2.73M-2.89M-2.38M-2.75M-4.12M-1.06M0.18M2.10M-1.36M-1.20M-1.26M-1.28M2.45M-0.01M-0.04M
Additional items
Exchange Rate EffectFX Effect
-0.04M-0.08M-0.03M0.04M0.30M-0.35M0.07M-0.02M-0.19M-0.18M-0.15M0.00M0.37M-0.36M0.34M0.63M-0.08M0.04M-0.23M0.03M
Change in Cash
-0.69M2.27M-2.39M-1.17M0.89M-0.64M-0.72M0.54M1.02M-1.06M-0.03M-0.21M0.52M-0.46M1.44M1.90M-0.63M1.80M-1.52M-0.60M
Ending Cash Balance
5.55M7.82M5.43M4.26M5.14M4.51M3.79M4.32M5.34M4.28M4.26M4.05M4.57M4.11M5.55M7.44M6.82M8.61M7.10M6.50M
Free Cash FlowFCF
-1.14M-0.24M-2.46M-0.63M0.21M2.44M1.59M3.04M4.14M3.47M0.76M-1.66M-1.72M1.42M2.47M2.67M0.88M-0.55M-1.09M-0.36M
Net Cash FlowNCF
-0.65M2.35M-2.36M-1.21M0.58M-0.29M-0.79M0.55M1.21M-0.87M0.12M-0.21M0.15M-0.10M1.10M1.26M-0.54M1.75M-1.29M-0.63M
Interest Paid
0.00M0.74M0.38M0.46M0.68M0.79M1.17M0.98M0.86M0.79M0.77M0.75M0.85M0.87M0.80M0.78M0.97M1.05M1.28M1.29M
Income Taxes PaidTaxes Paid
0.34M0.07M0.11M0.25M0.14M0.04M-0.13M0.25M0.05M0.04M0.03M0.11M0.18M-0.47M0.00M0.05M0.00M-0.01M-0.16M

Harvard Bioscience Cash Flow Statement API

Pull Harvard Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HBIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY